Call us on
2393-833 or 2394-065
VERAcity is a new generation non-invasive prenatal test (NIPT) for the detection of fetal chromosomal aneuploidies and microdeletions. It uses proprietary technology based on cutting-edge research and development in molecular genetics and bioinformatics. It was specifically designed by NIPD Genetics to avoid technical limitations and shortcomings of other NIPT.Additional information...
VERAgene needs a maternal blood sample during pregnancy, and a buccal swab sample from the biological father. The maternal blood contains cell-free DNA (cfDNA) from both the mother and the fetus. The cfDNA is isolated and analyzed independently for aneuploidies and microdeletions, and concurrently with the paternal DNA sample for parental carrier status determination for monogenic diseases using our proprietary technology. Sophisticated algorithms are then used to compute the risk of the fetus having an aneuploidy, microdeletion or monogenic disease. The results are sent to the clinician who communicates them to the parents and provides the necessary counselling. You should be at least 10 weeks pregnant to be able to do VERAgene test. The test results will be sent to your doctor in 14 working days.